Published in Medical Letter on the CDC and FDA, January 25th, 2009
The U.S. Food and Drug Administration relabeled warfarin in 2007 to recommend that patients receive genetic testing prior to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.